2024-510891-20-00CompletedPhase 1
Monitoring the AD effects of ketamine in MDD patients
Source: EU CTIS (euclinicaltrials.eu) · Last updated 19 Jul 2024
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- First submitted
- 4 Mar 2024
- Start date
- 1 Jun 2024
- Lead sponsor
- Centre for Human Drug Research
- Diseases
- Depression
- EU CT number
- 2024-510891-20-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 12
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre for Human Drug Research | Leiden | Netherlands | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.